Enforcement
We enforce federal competition and consumer protection laws that prevent anticompetitive, deceptive, and unfair business practices.
,
Search or browse
the Legal Library
Find legal resources and guidance to understand your business responsibilities and comply with the law.
,
Take action
- Report an antitrust violation
- File adjudicative documents
- Find banned debt collectors
- View competition guidance
,
Competition Matters,
,
Policy
We work to advance government policies that protect consumers and promote competition.
,
Search or browse
the Legal Library
Find legal resources and guidance to understand your business responsibilities and comply with the law.
,
Take action
,
Technology Blog,
Staff in the Office of Technology and The Division of Privacy and Identity Protection,
,
Advice and Guidance
Learn more about your rights as a consumer and how to spot and avoid scams. Find the resources you need to understand how consumer protection law impacts your business.
,
Take action
- Report fraud
- Report identity theft
- Register for Do Not Call
- Sign up for consumer alerts
- Get Business Blog updates
- Get your free credit report
- Find refund cases
- Order bulk publications
,
Consumer Advice
- Shopping and Donating
- Credit, Loans, and Debt
- Jobs and Making Money
- Unwanted Calls, Emails, and Texts
- Identity Theft and Online Security
- Scams
,
Business Guidance
- Advertising and Marketing
- Credit and Finance
- Privacy and Security
- By Industry
- For Small Businesses
- Browse Business Guidance Resources
- Business Blog
,
Servicemembers:
Your tool for financial readiness
,
Get consumer protection basics, plain and simple
,
Learn how the FTC protects free enterprise and consumers
,
Looking for competition guidance?
,
News and Events
,
,
–
,
Follow us on social media
,
About the FTC
Our mission is protecting consumers and competition by preventing anticompetitive, deceptive, and unfair business practices through law enforcement, advocacy, and education without unduly burdening legitimate business activity.
,
Looking for legal documents or records? Search the Legal Library instead.
,
Looking for legal documents or records? Search the Legal Library instead.
,
For Release,
Case was part of the Commission’s efforts to combat COVID-related health fraud,
,
The Federal Trade Commission today announced a proposed settlement that would ban California-based Precision Patient Outcomes, Inc. (PPO) and the company’s CEO Margrett Priest Lewis from claiming that dietary supplements can treat, prevent, or mitigate COVID-19.
“The order announced today bans PPO and its owner from making COVID-related health claims and unsubstantiated health claims generally” said Samuel Levine, Director of the FTC’s Bureau of Consumer Protection. “It is a reminder to the marketplace that competent and reliable scientific evidence is compulsory when advertising health-related claims.”
According to the FTC’s complaint, the defendants began advertising COVID Resist on the company’s website and social media pages during the pandemic with deceptive claims that the product could treat, prevent, or mitigate COVID-19.
Despite learning about the Commission’s enforcement action under the COVID-19 Consumer Protection Act against a company making similar claims about the science and efficacy of its products, the defendants only changed the name of the product from COVID Resist to VIRUS Resist and continued to deceptively advertise it as an effective treatment for COVID-19.
Based on this conduct, the FTC alleged that the defendants violated the FTC Act by: 1) making unsubstantiated efficacy claims for their product and 2) falsely claiming to have scientific evidence to support their health claims.
The proposed order settling the complaint addresses each of the defendants’ alleged violations of the FTC Act. First, it bans Precision Patient Outcomes and Lewis from making any claims that any product prevents or reduces the likelihood of infection with, or transmission of, the COVID-19 virus; that any product reduces the severity or duration of COVID-19; or otherwise cures, mitigates, or treats COVID-19, unless the FDA has approved the claim.
As in other Commission cases involving false or deceptive COVID-19 “treatments” or “cures,” the order bans the defendants from representing that any drug, food, or dietary supplement cures, mitigates or treats any disease unless they have competent and reliable scientific evidence to support the claims made. The order also prohibits the defendants from misrepresenting the health benefits or efficacy of any drug, food, or dietary supplement or the results of any tests or studies.
Finally, the order requires the defendants to possess and preserve all scientific evidence used to support the health claims made for products they sell. They also must notify customers and resellers about the FTC’s lawsuit.
The Commission vote authorizing the staff to file the proposed order was 3-0. It was filed in the U.S. District Court for the Northern District of California, Oakland Division.
NOTE: Stipulated final orders or injunctions have the force of law when approved and signed by the District Court judge.
The lead staff attorney on this matter was Abdiel T. Lewis of the FTC’s Western Region San Francisco
,
The Federal Trade Commission works to promote competition and protect and educate consumers. Learn more about consumer topics at consumer.ftc.gov, or report fraud, scams, and bad business practices at ReportFraud.ftc.gov. Follow the FTC on social media, read consumer alerts and the business blog, and sign up to get the latest FTC news and alerts.
,
Office of Public Affairs,
202-326-2161
